This study also reported that pharmacological inhibition of MPO through treatment with AZM198, an MPO inhibitor, could repress NASH progression and liver fibrosis induced by feeding a high-fat, high-cholesterol diet (HFHCD) (91). The gene discussed is MPO; the disease is Hepatic fibrosis.